BNP Paribas Financial Markets
CHTP

BNP Paribas Financial Markets’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

BNP Paribas Financial Markets’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-870
Closed -$3.85K – 4188
2013
Q4 		$3.85K Sell
870
-17,778
-95% -$60.1K ﹤0.01% 3277
2013
Q3 		$55.8K Sell
18,648
-10,629
-36% -$30.5K ﹤0.01% 2499
2013
Q2 		$67.3K Buy
+29,277
New +$59.2K ﹤0.01% 2617

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's CHTP Position: Q1 2014 in Review

BNP Paribas Financial Markets sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 870 shares — an estimated $3.85K sold.

BNP Paribas Financial Markets first reported a position in CHTP in Q2 2013 and held it in 3 quarters. The position peaked at $67.3K in Q2 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • BNP Paribas Financial Markets reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 870 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $3.85K.
  • BNP Paribas Financial Markets first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's CHELSEA THERAPEUTICS INT'L LTD position peaked at $67.3K in Q2 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.